SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-026339
Filing Date
2021-04-12
Accepted
2021-04-12 15:16:24
Documents
1
Period of Report
2021-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3863
  Complete submission text file 0001209191-21-026339.txt   5178
Mailing Address P.O. BOX 675614 RANCHO SANTA FE CA 92067
Business Address P.O. BOX 675614 RANCHO SANTA FE CA 92067 619-733-3852
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address
Harrison Kenneth Ph.D. (Reporting) CIK: 0001852977 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 21820557